TREM2-deficient xMGs or xMGs carrying the TREM2-R47H variant associated with high AD risk showed defects in clustering around amyloid plaques, phagocytosis, and expression of DAM markers [105, 106]. This evidence concerns the gene TREM2 and Alzheimer disease.